HIV treatment decision support program
Part of Infections clinical trials.
This study is testing a program to help people with HIV stick with their medication. It looks at how well doctors and patients work together to make treatment decisions and improve health outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You have HIV and are either starting treatment for the first time, restarting after a break, or already on ART at a participating clinic
- You are willing to be contacted by phone
- You are either a patient in early treatment at a study clinic OR a staff member who helps deliver the program
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program that helps people with HIV manage depression and stick to their treatment. It's for adults in Cape Town, South Africa, who have a detectable HIV viral load or may have one, and who show signs of depression.
This study tests a program to help people in Malawi stay on their HIV treatment even when they travel or move around. Researchers want to know if extra support can prevent gaps in care.
This study tests a program to help people living with HIV who have missed their recent treatment appointment get back on track. It aims to find better ways to support ongoing treatment.
This study tests a low-barrier, mobile HIV care program designed with input from patients and other stakeholders to help people stay engaged in care and reach an undetectable viral load. It may help if you’re having trouble keeping regular HIV appointments or staying on treatment.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This trial offers extra support for people who are starting or restarting HIV medication. It tests whether giving people a choice in their treatment support helps them stay healthy.
Hear when a new HIV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.